Liz Mckee Anderson

Liz McKee Anderson is the former Worldwide Vice President, Infectious Disease and Vaccines at Janssen Pharmaceuticals, Inc. Liz has more than 30 years of leadership in biotechnology, pharmaceuticals, and vaccines. She held senior leadership positions at Johnson & Johnson between 2003 and her retirement in 2014. Liz most recently served as Worldwide Vice President, Infectious Disease and Vaccines for Janssen Pharmaceuticals, a Johnson & Johnson company, where she directed the commercial development of an extensive portfolio of antivirals and vaccines with responsibility for global strategic marketing, market access, and global analytics for that division. She previously served in WWVP roles for Biotechnology, Immunology and Oncology. Prior to Johnson & Johnson, Liz served as the Vice President and General Manager of Wyeth Lederle Vaccines from 1997 to 2002, where she was responsible for a broad product portfolio and the commercialization and launch of the PREVNAR vaccine. She also previously worked in executive leadership roles at Rhone Poulenc Rorer and the American National Red Cross. Liz also serves on the boards of directors of BioMarin Pharmaceutical Inc., Insmed, Inc., Revolution Medicines Inc., Bavarian Nordic A/S and Context Therapeutics, previously served on the board of global marketing and communications company Huntsworth Plc and is a trustee of the Wistar Institute for Biomedical Research. Liz holds a Bachelor of Science in Engineering from Rutgers University and a Master of Business Administration from Loyola University Maryland.